• Wed, February 21, 2024

by: WOPRAI

John Ivankoe Downgraded (WEN) to Hold and Decreased Target to $19 on, Feb 21st, 2024

by: WOPRAI

Scott Searle Downgraded (VZIO) to Hold and Held Target at $12 on, Feb 21st, 2024

by: WOPRAI

Daniel Day Downgraded (VZIO) to Hold and Increased Target to $12 on, Feb 21st, 2024

by: WOPRAI

Jason Kreyer Downgraded (VZIO) to Hold on, Feb 21st, 2024

by: WOPRAI

Cory Carpenter Downgraded (VZIO) to Hold and Increased Target to $12 on, Feb 21st, 2024

by: WOPRAI

Joseph Feldman Maintained (WMT) at Buy with Increased Target to $68 on, Feb 21st, 2024

by: WOPRAI

Scot Ciccarelli Maintained (WMT) at Hold with Increased Target to $60 on, Feb 21st, 2024

by: WOPRAI

Edward Yruma Maintained (WMT) at Buy with Increased Target to $76 on, Feb 21st, 2024

by: WOPRAI

Kelly Bania Maintained (WMT) at Buy with Increased Target to $65 on, Feb 21st, 2024

by: WOPRAI

Robert Drbul Maintained (WMT) at Strong Buy with Increased Target to $67 on, Feb 21st, 2024

by: WOPRAI

Bradley Thomas Maintained (WMT) at Buy with Increased Target to $63 on, Feb 21st, 2024

by: WOPRAI

Matthew McKellar Reiterated (WFG) at Buy and Held Target at $97 on, Feb 21st, 2024

by: WOPRAI

Bernie McTernan Reiterated (WIX) at Strong Buy and Held Target at $150 on, Feb 21st, 2024

by: WOPRAI

John Royall Initiated (wkc) at Hold and Held Target at $25 on, Feb 21st, 2024

by: WOPRAI

Brad Reback Maintained (WK) at Hold with Decreased Target to $85 on, Feb 21st, 2024

by: WOPRAI

Daniel Jester Maintained (WK) at Buy with Decreased Target to $113 on, Feb 21st, 2024

by: WOPRAI

Steven Enders Maintained (WK) at Strong Buy with Decreased Target to $110 on, Feb 21st, 2024

by: WOPRAI

Joshua Long Reiterated (WING) at Buy and Held Target at $330 on, Feb 21st, 2024

by: WOPRAI

Andrew Charles Reiterated (WING) at Buy and Held Target at $295 on, Feb 21st, 2024

by: WOPRAI

Dana Telsey Reiterated (WRBY) at Buy and Held Target at $19 on, Feb 21st, 2024

by: WOPRAI

Stanley Elliott Maintained (WSC) at Strong Buy with Increased Target to $58 on, Feb 21st, 2024

by: WOPRAI

Seth Weber Maintained (WSC) at Buy with Increased Target to $57 on, Feb 21st, 2024

by: WOPRAI

Greg Barnes Downgraded (WPM) to Hold on, Feb 21st, 2024

by: WOPRAI

Bill Maughan Reiterated (BNTX) at Strong Buy and Held Target at $171 on, Feb 21st, 2024

by: WOPRAI

Jeff Jones Reiterated (VTYX) at Hold on, Feb 21st, 2024

by: WOPRAI

James Thalacker Maintained (VST) at Buy with Increased Target to $52 on, Feb 21st, 2024

by: WOPRAI

Colin Bristow Downgraded (BTAI) to Hold and Decreased Target to $4 on, Feb 21st, 2024

by: WOPRAI

Trevor Young Maintained (ZG) at Sell with Increased Target to $40 on, Feb 21st, 2024

by: WOPRAI

Trevor Young Maintained (Z) at Sell with Increased Target to $40 on, Feb 21st, 2024

by: WOPRAI

Dana Telsey Reiterated (ZVIA) at Hold and Held Target at $4 on, Feb 21st, 2024

by: WOPRAI

Elyse Greenspan Maintained (AIG) at Hold with Increased Target to $74 on, Feb 21st, 2024

by: WOPRAI

Sarah Akers Maintained (ALE) at Hold with Increased Target to $59 on, Feb 21st, 2024

by: WOPRAI

Joseph O"Dea Downgraded (ALLE) to Hold and Increased Target to $140 on, Feb 21st, 2024

by: WOPRAI

Julian Mitchell Maintained (ALLE) at Hold with Increased Target to $121 on, Feb 21st, 2024

by: WOPRAI

Luca Issi Reiterated (ALNY) at Buy and Held Target at $235 on, Feb 21st, 2024

by: WOPRAI

Charles Duncan Maintained (AXSM) at Buy with Decreased Target to $103 on, Feb 21st, 2024

by: WOPRAI

Leonid Timashev Maintained (AXSM) at Buy with Decreased Target to $123 on, Feb 21st, 2024

by: WOPRAI

Yatin Suneja Maintained (AXSM) at Strong Buy with Increased Target to $125 on, Feb 21st, 2024

by: WOPRAI

Christopher Danely Maintained (ADI) at Strong Buy with Increased Target to $220 on, Feb 21st, 2024

by: WOPRAI

Alex Schwartz Initiated (ANAB) at Strong Buy and Held Target at $50 on, Feb 21st, 2024

by: WOPRAI

Derrick Whitfield Maintained (AMTX) at Strong Buy with Decreased Target to $6.5 on, Feb 21st, 2024

by: WOPRAI

Lucas Pipes Maintained (AMRK) at Strong Buy with Decreased Target to $33 on, Feb 21st, 2024

by: WOPRAI

Clarke Jeffries Reiterated (AMPL) at Hold and Held Target at $11 on, Feb 21st, 2024

by: WOPRAI

Tyler Radke Maintained (AMPL) at Hold with Decreased Target to $13 on, Feb 21st, 2024

by: WOPRAI

Nick Altmann Downgraded (AMPL) to Hold and Decreased Target to $12 on, Feb 21st, 2024

by: WOPRAI

Philip Gibbs Maintained (ATI) at Buy with Increased Target to $51 on, Feb 21st, 2024

by: WOPRAI

Keith Hughes Maintained (AWI) at Strong Buy with Increased Target to $131 on, Feb 21st, 2024

by: WOPRAI

Susan Maklari Maintained (AWI) at Strong Buy with Increased Target to $132 on, Feb 21st, 2024

Colin Bristow Downgraded (BTAI) to Hold and Decreased Target to $4 on, Feb 21st, 2024

Colin Bristow of UBS, Downgraded "BioXcel Therapeutics, Inc." (BTAI) to Hold and Decreased Target from $9 to $4 on, Feb 21st, 2024.

Colin has made no other calls on BTAI in the last 4 months.



There is 1 other peer that has a rating on BTAI. Out of the 1 peers that are also analyzing BTAI, 0 agree with Colin's Rating of Hold.



This is the rating of the analyst that currently disagrees with Colin

  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $11 on, Wednesday, November 15th, 2023

Like: 👍